TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial…
Spotlight delivers real-time cash flow visibility so lenders can reduce risk, cut complexity, and respond faster in a volatile marketNEW…
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…
June 03, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June 3, 2025 - Addex Therapeutics (SIX: ADXN and…